Skip to main content


Jodi Decker Virkus is the Executive Director, Hematology and Breast Cancer Global Pipeline Strategy at Novartis Pharmaceuticals with responsibility for development strategies to maximize the early portfolio. She began her career in 1998 at Glaxo Wellcome in Clinical Development for Breast Cancer. During the course of 20 years of experience, she led teams as a Medical Director for early to late stage oncology programs and Marketing Launch Lead in the US and Global for both solid tumor and hematologic therapies.  She has focused on the development of orphan drug research and areas of high unmet need with small molecules, antibodies, cellular and gene therapies.

Jodi received her BSPharm from Oregon State University and her PharmD from the University of North Carolina at Chapel Hill.